Xiaolu Xiong Selected Research

Infections

10/2023	Manganese-Based Nanoparticle Vaccine for Combating Fatal Bacterial Pneumonia.
1/2023	Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model.
1/2023	Lysosomal trafficking regulator restricts intracellular growth of Coxiella burnetii by inhibiting the expansion of Coxiella-containing vacuole and upregulating nos2 expression.
6/2022	Ultrasmall Fe-doped carbon dots nanozymes for photoenhanced antibacterial therapy and wound healing.
1/2022	Degradable Pseudo Conjugated Polymer Nanoparticles with NIR-II Photothermal Effect and Cationic Quaternary Phosphonium Structural Bacteriostasis for Anti-Infection Therapy.
1/2022	Development of a Lateral Flow Strip-Based Recombinase-Aided Amplification for Active Chlamydia psittaci Infection.
5/2021	Identification of tick-borne pathogens by metagenomic next-generation sequencing in Dermacentor nuttalli and Ixodes persulcatus in Inner Mongolia, China.
1/2019	Pathologic changes and immune responses against Coxiella burnetii in mice following infection via non-invasive intratracheal inoculation.
1/2019	Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
12/2017	Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaolu Xiong Research Topics

Disease

15	Infections 10/2023 - 03/2012
12	Q Fever (Fever, Q) 12/2024 - 09/2011
5	Rocky Mountain Spotted Fever (Sao Paulo Typhus) 02/2024 - 01/2014
4	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2016 - 03/2012
3	Plague (Bubonic Plague) 10/2023 - 01/2020
2	Bites and Stings (Sting) 02/2024 - 10/2023
2	Snoring 01/2020 - 01/2016
2	Insulin Resistance 09/2019 - 03/2019
2	Obstructive Sleep Apnea 05/2016 - 01/2014
1	Bacterial Pneumonia 10/2023
1	Human Influenza (Influenza) 01/2023
1	COVID-19 01/2023
1	Anthrax 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Zoonoses 01/2022
1	Tick Bites 05/2021
1	Coinfection 01/2021
1	Hyperuricemia 01/2020
1	Obesity 09/2019
1	Liver Diseases (Liver Disease) 03/2019
1	Neutropenia 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Brucellosis (Malta Fever) 12/2014
1	Mycoplasma Pneumonia 12/2014
1	Rickettsia Infections 01/2013
1	Pneumonia (Pneumonitis) 03/2012

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 10/2023 - 01/2013
7	AntigensIBA 10/2023 - 05/2013
6	Proteins (Proteins, Gene)FDA Link 02/2015 - 03/2012
4	Membrane Proteins (Integral Membrane Proteins)IBA 02/2015 - 09/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2024 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2021
3	InterferonsIBA 02/2024 - 01/2015
3	Subunit VaccinesIBA 01/2022 - 05/2013
3	LipidsIBA 01/2020 - 03/2019
2	Interferon Type IIBA 02/2024 - 10/2023
2	tert-butylbicyclophosphorothionateIBA 05/2021 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 03/2019
2	Insulin (Novolin)FDA Link 09/2019 - 03/2019
2	AerosolsIBA 01/2019 - 01/2019
2	Peptides (Polypeptides)IBA 12/2017 - 01/2014
2	EpitopesIBA 12/2017 - 01/2014
2	Immunoglobulin G (IgG)IBA 02/2015 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2014
1	Viral DNAIBA 02/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024
1	SilicatesIBA 10/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2023
1	NanovaccinesIBA 10/2023
1	ManganeseIBA 10/2023
1	bismuth selenideIBA 01/2023
1	stearylamineIBA 01/2023
1	Type IV Secretion SystemsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	CollagenIBA 06/2022
1	AcidsIBA 01/2022
1	Recombinases (Recombinase)IBA 01/2022
1	PolymersIBA 01/2022
1	Uric Acid (Urate)IBA 01/2020
1	Attenuated VaccinesIBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2019
1	Chloroform (Trichloromethane)IBA 01/2019
1	Methanol (Carbinol)IBA 01/2019
1	InterleukinsIBA 05/2016
1	Interleukin-6 (Interleukin 6)IBA 05/2016
1	MucinsIBA 01/2016
1	ORALIT (ORS)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	CytokinesIBA 01/2015
1	Pemetrexed (MTA)FDA Link 01/2015
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2014
1	Recombinant ProteinsIBA 11/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2011
1	Immunodominant EpitopesIBA 09/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2015